Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X:
“Now out in Blood Cancer Journal – fascinating work by Andrew Yee, Noopur Raje et al looking at visceral EMD.
I was today years old when I learned TP53 can have gain-of-function mutations making it (?) oncogenic in Multiple Myeloma.”
Authors: Rie Nakamoto-Matsubara et al.
Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.
He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.